Foghorn Therapeutics Inc.
FHTX
Revenue
6.89M
▲1.84M▲36.40%
3 Months ChangeAssets
328.59M
▲73.58M▲28.85%
3 Months ChangeLiabilities
342.91M
▼-9.58M▼-2.72%
3 Months ChangeFree Cash Flow
-29.45M
▲2.37M▲7.45%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-10
Form 8-K
ID: 0001628280-24-042630
2024-08-08
Form 10-Q
ID: 0001628280-24-035867
2024-08-08
Form 8-K
ID: 0001628280-24-035864
2024-06-26
Form 8-K
ID: 0001628280-24-030137
2024-06-03
Form 8-K
ID: 0001628280-24-026294
2024-05-23
Form 8-K
ID: 0001628280-24-024811
2024-05-22
Form 8-K
ID: 0001193125-24-144934
2024-05-20
Form 8-K
ID: 0001628280-24-024217
2024-05-06
Form 8-K
ID: 0001628280-24-020698
2024-05-06
Form 10-Q
ID: 0001628280-24-020455